Cannabinoids By Design
Lygos uses a fermentation-based technology to enable the production of highly pure and consistent cannabinoids for consumer and pharmaceutical applications. We are harnessing the power of biology to unlock the therapeutic potential of nature.
Compelling Advantages
The Lygos Difference
Performance
- Unique Process – Our modular platform provides access to plant-based or novel cannabinoids allowing for customizable formulations, differentiated products and unique branding.
- High Quality – Our bio-based production platform enables high-value products and important quality control features that ensure consistent and replicable ingredients over time.
- High Purity – Our ultra-pure products unlock new applications, ranging from high-performance consumer products to active pharmaceutical ingredients.
Sustainable
- Following Nature – Our system is modeled after the plant’s cannabinoid production process resulting in structurally identical finished products.
- Highly Scalable – Our products deliver innovation beyond the plant, enabling us to meet the growing needs of the cannabis industry.
- Reduced Footprint – Our efficient production process reduces land use, decreases energy requirements and eliminates the need for fertilizers and pesticides.
Economical
- Lower costs – Our process delivers the industry’s lowest cost solution for cannabinoid manufacturing across many important cannabinoids.
- Traceability – Our process takes days to produce cannabinoids at scale and can be traced versus long cycle times at indoor or outdoor farms.
- Broad Presence – Our unique production process can open doors to many geographies that are inaccessible by the plant today.
Performance
- Unique Process
- High Quality
- High Purity
Sustainable
- Following Nature
- Highly Scalable
- Reduced Footprint
Economical
- Lower Costs
- Traceability
- Broad Presence
Common, Rare, Novel
Products
CBG
CBG
CBC
CBC
CBD
CBD
CBN
CBN
CBGA
CBGA
CBCA
CBCA
CBDA
CBDA
CBDV
CBDV
CBG
Cannabigerol (CBG) is a non-psychoactive cannabinoid that is believed to have antibacterial, anti-inflammation, antioxidant, and neuroprotective applications. CBG is currently being used in nutritional and cosmetic product applications.
Buy Now
CBC
Cannabichromene (CBC) is a non-psychoactive cannabinoid, which is produced at low levels by the cannabis plant that is believed to have antioxidant and antiinflammatory properties. CBC has potential applications in pain and skin related health, and has been demonstrated to promote neurogenesis and inhibit tumors and cancers.
Buy Now
CBD
Cannabidiol (CBD) is a non-psychoactive cannabinoid produced in high abundance by the cannabis and hemp plants. CBD is one of the most well characterized cannabinoids with applications as a therapeutic for epilepsy and other neurological and anxiety disorders.
Buy Now
CBN
Cannabinol (CBN) is a cannabinoid that is produced from the oxidation or degradation of other cannabinoid compounds, but is found in only small quantities in the plant. Studies have shown that CBN has applications for pain, inflammation and insomnia.
Buy Now
CBGA
Cannabigerolic Acid (CBGA) is a non-psychoactive cannabinoid and is considered the “stem cell” of cannabinoids since all pentyl side chain cannabinoids are derived from CBGA. Studies into the effects of CBGA have shown that it has similar anti-inflammatory and anti-anxiety benefits to that of its daughter molecules.
Buy Now
CBCA
Cannabichromenic acid (CBCA) is a non-psychoactive cannabinoid that is believed to have applications as an anti-inflammatory, antimicrobial and analgesic compound.
Buy Now
CBDA
Cannabidiolic acid (CBDA) is a non-psychoactive cannabinoid and the precursor to CBD. While similar in structure to CBD, studies have shown that this compound has improved anti-nausea and anti-anxiety effects.
Buy Now
CBDV
Cannabidivarin (CBDV) is a non-psychoactive cannabinoid produced in low abundance by the cannabis/hemp plant. CBDV is similar in structure to CBD and is being investigated as an anti-seizure and anti-inflammation product.
Buy Now
Leading Capabilities
Services
Bulk Supply
Large-scale production with unmatched reliability
Lygos specializes in large-scale production and commercialization of cannabinoids ranging from orders of scale to 10s to 1,000s of kilograms. Our consistency helps our partners plan ahead to eliminate risks of product availability or diminished quality at large scale from various plant supplied sources. We provide dependable wholesale supply solutions for a variety of cannabinoids at unmatched reliability across several geographical areas that are inaccessible by the plant today.
Formulation
Unique mixtures for new and existing markets
Lygos’ ability to access a wide variety of cannabinoids enables us to create unique products to address existing and new markets. We work with our partners to formulate specific desired mixtures as powders, liquids or other physical forms. The addition of our materials will help enhance existing properties, working together to do more than any single component.
Custom Synthesis
Full-service design and production
Lygos works with our partners to design and produce plant-based or novel compounds from the bench to commercial scale. Our exclusive cannabinoid production platform supports both plant and non-plant-derived cannabinoids, providing our partners with unique building blocks and significant time and effort savings. Our ability to design unique molecules, especially polyketides, have shown promising applications in both pharmaceutical and nutraceutical applications.
Efficacy
Safety and toxicology expertise
Lygos’ rigorous scientific team possesses extensive understanding of cannabinoids. This allows us to focus not only on manufacturing, but also how the molecules operate and potential benefits of working together within the human endocannabinoid system. Our team of experts has the ability to work with partners in early stage toxicology and efficacy tests, ensuring the right cannabinoid and/or cannabinoid formulation is selected for the right application.
Leading Capabilities
Services
Bulk Supply
Large-scale production with unmatched reliability
Lygos specializes in large-scale production and commercialization of cannabinoids ranging from orders of scale to 10s to 1,000s of kilograms. Our consistency helps our partners plan ahead to eliminate risks of product availability or diminished quality at large scale from various plant supplied sources. We provide dependable wholesale supply solutions for a variety of cannabinoids at unmatched reliability across several geographical areas that are inaccessible by the plant today.
Formulation
Unique mixtures for new and existing markets
Lygos’ ability to access a wide variety of cannabinoids enables us to create unique products to address existing and new markets. We work with our partners to formulate specific desired mixtures as powders, liquids or other physical forms. The addition of our materials will help enhance existing properties, working together to do more than any single component.
Custom Synthesis
Full-service design and production
Lygos works with our partners to design and produce plant-based or novel compounds from the bench to commercial scale. Our exclusive cannabinoid production platform supports both plant and non-plant-derived cannabinoids, providing our partners with unique building blocks and significant time and effort savings. Our ability to design unique molecules, especially polyketides, have shown promising applications in both pharmaceutical and nutraceutical applications.
Efficacy
Safety and toxicology expertise
Lygos’ rigorous scientific team possesses extensive understanding of cannabinoids. This allows us to focus not only on manufacturing, but also how the molecules operate and potential benefits of working together within the human endocannabinoid system. Our team of experts has the ability to work with partners in early stage toxicology and efficacy tests, ensuring the right cannabinoid and/or cannabinoid formulation is selected for the right application.
Safe, Sustainable, Cost-Effective
Platform
At the core of Lygos’ cannabinoid discovery and development platform is our Bio-Innovation Engine. The efficiency and modularity built into the platform allows for large-scale production of different cannabinoids, even those that are not easily accessible through traditional agricultural means. We strive to deliver our naturally derived cannabinoids at costs that enable everyday consumer products and novel compounds for the next generation of cannabinoid-inspired pharmaceutical care.
Learn more about our platform
Contact Us
FAQs
Partner with Us
Lygos is interested in forming strategic partnerships that will enable us to deliver new cannabinoid-enabled products for high-growth consumer market segments. Contact us today to learn more about how we can work together.
About Lygos CBx
Lygos CBx delivers low-cost, large-scale supply of high-quality, pure and sustainable cannabinoid compounds. The cannabinoids are designed to enhance numerous consumer products, as well as health & wellness and pharmaceutical applications.
Partner with Us
Lygos is interested in forming strategic partnerships that will enable us to deliver new cannabinoid-enabled products for high-growth consumer market segments. Contact us today to learn more about how we can work together.
About Lygos CBx
Lygos CBx delivers low-cost, large-scale supply of high-quality, pure and sustainable cannabinoid compounds. The cannabinoids are designed to enhance numerous consumer products, as well as health & wellness and pharmaceutical applications.